S-7 cell adhesion peptide (Transition Therapeutics)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug NameS-7 cell adhesion peptide (Transition Therapeutics)

Drug Alias Namemultiple sclerosis therapeutic peptide (Transition Therapeutics)diabetes therapeutic peptide (Transition Therapeutics)restenosis therapeutic peptide (Transition Therapeutics)

ClassificationBiologics > Protein drugs > Recombinant polypeptide

Mechanisms of ActionCell adhesion molecules modulators

TargetsCell adhesion molecules

Therapy Area/IndicationsDiabetes MellitusCoronary RestenosisMultiple Sclerosis

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryCanada

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesTransition Therapeutics Inc

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesTransition Therapeutics Inc

Active IndicationsN/A

Inactive IndicationsDiabetes MellitusCoronary RestenosisMultiple Sclerosis

Other Information

ATC CodeN/A